The global eosinophilic esophagitis market is expected to reach USD 1,927 million by 2030, at a CAGR of 34% during the forecast period 2022 to 2030. This industry is growing because there are more people with rare diseases around the world and the market is growing. White blood cell-related autoimmune diseases are becoming more common, which is driving the market for diseases caused by eosinophils.